Every day of the week at 8.15 am, Sonia Mabrouk receives a topical guest in the morning of Europe 1. This Monday, it is the president of Sanofi France, Olivier Bogillot, who answers his questions.
The boss of Sanofi France, Olivier Bogillot, is the guest of Sonia Mabrouk Monday in the morning of Europe 1. While the French laboratory has fallen behind in the preparation of a vaccine against the coronavirus, this one, developed based on a recombinant protein, is still in the testing phase. The results of phase 2 are due on Monday morning. The group also announced two months ago the launch of the first human trials of its second project, this time on the model of messenger RNA. So is the vaccine race permanently lost for Sanofi?